nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DGUOK—telencephalon—Alzheimer's disease	0.0176	0.157	CbGeAlD
Nelarabine—DGUOK—nervous system—Alzheimer's disease	0.0104	0.0925	CbGeAlD
Nelarabine—DGUOK—central nervous system—Alzheimer's disease	0.01	0.0891	CbGeAlD
Nelarabine—DGUOK—cerebellum—Alzheimer's disease	0.00979	0.0871	CbGeAlD
Nelarabine—DCK—embryo—Alzheimer's disease	0.00824	0.0733	CbGeAlD
Nelarabine—DGUOK—brain—Alzheimer's disease	0.00796	0.0707	CbGeAlD
Nelarabine—ADA—p73 transcription factor network—BIN1—Alzheimer's disease	0.00729	0.0907	CbGpPWpGaD
Nelarabine—DCK—telencephalon—Alzheimer's disease	0.00671	0.0596	CbGeAlD
Nelarabine—Adenosine monophosphate—CREB1—Alzheimer's disease	0.00615	0.508	CrCbGaD
Nelarabine—POLA1—cerebellum—Alzheimer's disease	0.00604	0.0537	CbGeAlD
Nelarabine—ADA—nervous system—Alzheimer's disease	0.00596	0.0529	CbGeAlD
Nelarabine—ADA—central nervous system—Alzheimer's disease	0.00573	0.051	CbGeAlD
Nelarabine—POLA1—brain—Alzheimer's disease	0.00491	0.0436	CbGeAlD
Nelarabine—ADA—brain—Alzheimer's disease	0.00455	0.0405	CbGeAlD
Nelarabine—DCK—nervous system—Alzheimer's disease	0.00396	0.0352	CbGeAlD
Nelarabine—DCK—central nervous system—Alzheimer's disease	0.00381	0.0339	CbGeAlD
Nelarabine—DCK—cerebellum—Alzheimer's disease	0.00373	0.0331	CbGeAlD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—YWHAQ—Alzheimer's disease	0.00354	0.0441	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—ABCA1—Alzheimer's disease	0.00343	0.284	CrCbGaD
Nelarabine—DCK—brain—Alzheimer's disease	0.00303	0.0269	CbGeAlD
Nelarabine—Mental disability—Rivastigmine—Alzheimer's disease	0.00288	0.00363	CcSEcCtD
Nelarabine—Sepsis—Rivastigmine—Alzheimer's disease	0.00288	0.00363	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—PIN1—Alzheimer's disease	0.00279	0.0348	CbGpPWpGaD
Nelarabine—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00278	0.0035	CcSEcCtD
Nelarabine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00273	0.00343	CcSEcCtD
Nelarabine—Pneumonia—Galantamine—Alzheimer's disease	0.00271	0.00341	CcSEcCtD
Nelarabine—Osteoarthritis—Donepezil—Alzheimer's disease	0.00271	0.00341	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—TP73—Alzheimer's disease	0.0027	0.0336	CbGpPWpGaD
Nelarabine—Depression—Galantamine—Alzheimer's disease	0.00269	0.00338	CcSEcCtD
Nelarabine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.00265	0.00333	CcSEcCtD
Nelarabine—Amnesia—Memantine—Alzheimer's disease	0.00262	0.0033	CcSEcCtD
Nelarabine—Amnesia—Rivastigmine—Alzheimer's disease	0.00257	0.00323	CcSEcCtD
Nelarabine—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00255	0.00321	CcSEcCtD
Nelarabine—Ataxia—Donepezil—Alzheimer's disease	0.00255	0.00321	CcSEcCtD
Nelarabine—Epistaxis—Galantamine—Alzheimer's disease	0.00255	0.0032	CcSEcCtD
Nelarabine—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00254	0.0032	CcSEcCtD
Nelarabine—Hypoglycaemia—Memantine—Alzheimer's disease	0.00253	0.00318	CcSEcCtD
Nelarabine—Dehydration—Donepezil—Alzheimer's disease	0.00252	0.00317	CcSEcCtD
Nelarabine—Adenosine triphosphate—AKT1—Alzheimer's disease	0.00252	0.208	CrCbGaD
Nelarabine—Lethargy—Memantine—Alzheimer's disease	0.00251	0.00316	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—OGG1—Alzheimer's disease	0.00249	0.0309	CbGpPWpGaD
Nelarabine—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00247	0.00311	CcSEcCtD
Nelarabine—Hypokalaemia—Donepezil—Alzheimer's disease	0.00247	0.00311	CcSEcCtD
Nelarabine—Pain in extremity—Memantine—Alzheimer's disease	0.00246	0.0031	CcSEcCtD
Nelarabine—Osteoarthritis—Memantine—Alzheimer's disease	0.00246	0.0031	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.00244	0.00307	CcSEcCtD
Nelarabine—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00241	0.00303	CcSEcCtD
Nelarabine—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00241	0.00303	CcSEcCtD
Nelarabine—Muscular weakness—Donepezil—Alzheimer's disease	0.00239	0.00301	CcSEcCtD
Nelarabine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00239	0.00301	CcSEcCtD
Nelarabine—Oedema peripheral—Galantamine—Alzheimer's disease	0.00239	0.003	CcSEcCtD
Nelarabine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00238	0.00299	CcSEcCtD
Nelarabine—Urethral disorder—Galantamine—Alzheimer's disease	0.00238	0.00299	CcSEcCtD
Nelarabine—Abdominal distension—Donepezil—Alzheimer's disease	0.00236	0.00297	CcSEcCtD
Nelarabine—Ataxia—Memantine—Alzheimer's disease	0.00232	0.00291	CcSEcCtD
Nelarabine—Blood creatinine increased—Memantine—Alzheimer's disease	0.00231	0.0029	CcSEcCtD
Nelarabine—Dehydration—Memantine—Alzheimer's disease	0.00229	0.00288	CcSEcCtD
Nelarabine—Ataxia—Rivastigmine—Alzheimer's disease	0.00227	0.00285	CcSEcCtD
Nelarabine—Eye disorder—Galantamine—Alzheimer's disease	0.00226	0.00285	CcSEcCtD
Nelarabine—Cardiac disorder—Galantamine—Alzheimer's disease	0.00225	0.00283	CcSEcCtD
Nelarabine—Hypokalaemia—Memantine—Alzheimer's disease	0.00224	0.00282	CcSEcCtD
Nelarabine—Dehydration—Rivastigmine—Alzheimer's disease	0.00224	0.00282	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00222	0.00279	CcSEcCtD
Nelarabine—Angiopathy—Galantamine—Alzheimer's disease	0.0022	0.00276	CcSEcCtD
Nelarabine—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00219	0.00276	CcSEcCtD
Nelarabine—Muscular weakness—Memantine—Alzheimer's disease	0.00217	0.00273	CcSEcCtD
Nelarabine—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00213	0.00267	CcSEcCtD
Nelarabine—Mental disorder—Galantamine—Alzheimer's disease	0.00212	0.00267	CcSEcCtD
Nelarabine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00212	0.00266	CcSEcCtD
Nelarabine—Malnutrition—Galantamine—Alzheimer's disease	0.00211	0.00265	CcSEcCtD
Nelarabine—Pneumonia—Donepezil—Alzheimer's disease	0.0021	0.00265	CcSEcCtD
Nelarabine—Infestation NOS—Donepezil—Alzheimer's disease	0.00209	0.00263	CcSEcCtD
Nelarabine—Infestation—Donepezil—Alzheimer's disease	0.00209	0.00263	CcSEcCtD
Nelarabine—Depression—Donepezil—Alzheimer's disease	0.00209	0.00262	CcSEcCtD
Nelarabine—Dysgeusia—Galantamine—Alzheimer's disease	0.00207	0.0026	CcSEcCtD
Nelarabine—Back pain—Galantamine—Alzheimer's disease	0.00204	0.00257	CcSEcCtD
Nelarabine—Neutropenia—Memantine—Alzheimer's disease	0.00199	0.00251	CcSEcCtD
Nelarabine—Vision blurred—Galantamine—Alzheimer's disease	0.00199	0.0025	CcSEcCtD
Nelarabine—Tremor—Galantamine—Alzheimer's disease	0.00198	0.00249	CcSEcCtD
Nelarabine—Epistaxis—Donepezil—Alzheimer's disease	0.00197	0.00248	CcSEcCtD
Nelarabine—Anaemia—Galantamine—Alzheimer's disease	0.00195	0.00245	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—TP73—Alzheimer's disease	0.00194	0.0242	CbGpPWpGaD
Nelarabine—Hyperglycaemia—Memantine—Alzheimer's disease	0.00192	0.00242	CcSEcCtD
Nelarabine—Pneumonia—Memantine—Alzheimer's disease	0.00191	0.0024	CcSEcCtD
Nelarabine—Infestation—Memantine—Alzheimer's disease	0.0019	0.00239	CcSEcCtD
Nelarabine—Infestation NOS—Memantine—Alzheimer's disease	0.0019	0.00239	CcSEcCtD
Nelarabine—Depression—Memantine—Alzheimer's disease	0.00189	0.00238	CcSEcCtD
Nelarabine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00188	0.00236	CcSEcCtD
Nelarabine—Pneumonia—Rivastigmine—Alzheimer's disease	0.00187	0.00235	CcSEcCtD
Nelarabine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00187	0.00235	CcSEcCtD
Nelarabine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00186	0.00234	CcSEcCtD
Nelarabine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00186	0.00234	CcSEcCtD
Nelarabine—Infestation—Rivastigmine—Alzheimer's disease	0.00186	0.00234	CcSEcCtD
Nelarabine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00185	0.00233	CcSEcCtD
Nelarabine—Loss of consciousness—Galantamine—Alzheimer's disease	0.00185	0.00233	CcSEcCtD
Nelarabine—Depression—Rivastigmine—Alzheimer's disease	0.00185	0.00233	CcSEcCtD
Nelarabine—Oedema peripheral—Donepezil—Alzheimer's disease	0.00185	0.00233	CcSEcCtD
Nelarabine—Urethral disorder—Donepezil—Alzheimer's disease	0.00184	0.00232	CcSEcCtD
Nelarabine—Cough—Galantamine—Alzheimer's disease	0.00184	0.00231	CcSEcCtD
Nelarabine—Convulsion—Galantamine—Alzheimer's disease	0.00183	0.0023	CcSEcCtD
Nelarabine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00182	0.00229	CcSEcCtD
Nelarabine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.0018	0.00226	CcSEcCtD
Nelarabine—Myalgia—Galantamine—Alzheimer's disease	0.0018	0.00226	CcSEcCtD
Nelarabine—Arthralgia—Galantamine—Alzheimer's disease	0.0018	0.00226	CcSEcCtD
Nelarabine—Chest pain—Galantamine—Alzheimer's disease	0.0018	0.00226	CcSEcCtD
Nelarabine—Epistaxis—Memantine—Alzheimer's disease	0.00179	0.00225	CcSEcCtD
Nelarabine—Sinusitis—Memantine—Alzheimer's disease	0.00178	0.00224	CcSEcCtD
Nelarabine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00176	0.00221	CcSEcCtD
Nelarabine—Epistaxis—Rivastigmine—Alzheimer's disease	0.00175	0.0022	CcSEcCtD
Nelarabine—Sinusitis—Rivastigmine—Alzheimer's disease	0.00174	0.00219	CcSEcCtD
Nelarabine—Confusional state—Galantamine—Alzheimer's disease	0.00174	0.00218	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—IL1A—Alzheimer's disease	0.00173	0.0215	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—MPO—Alzheimer's disease	0.00172	0.0215	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Memantine—Alzheimer's disease	0.0017	0.00213	CcSEcCtD
Nelarabine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00169	0.00212	CcSEcCtD
Nelarabine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00169	0.00212	CcSEcCtD
Nelarabine—Chills—Donepezil—Alzheimer's disease	0.00168	0.00212	CcSEcCtD
Nelarabine—Urinary tract disorder—Memantine—Alzheimer's disease	0.00168	0.00212	CcSEcCtD
Nelarabine—Oedema peripheral—Memantine—Alzheimer's disease	0.00168	0.00211	CcSEcCtD
Nelarabine—Connective tissue disorder—Memantine—Alzheimer's disease	0.00168	0.00211	CcSEcCtD
Nelarabine—Urethral disorder—Memantine—Alzheimer's disease	0.00167	0.0021	CcSEcCtD
Nelarabine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00166	0.00209	CcSEcCtD
Nelarabine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00165	0.00207	CcSEcCtD
Nelarabine—Mental disorder—Donepezil—Alzheimer's disease	0.00165	0.00207	CcSEcCtD
Nelarabine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00164	0.00207	CcSEcCtD
Nelarabine—Anorexia—Galantamine—Alzheimer's disease	0.00164	0.00206	CcSEcCtD
Nelarabine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00164	0.00206	CcSEcCtD
Nelarabine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00163	0.00206	CcSEcCtD
Nelarabine—Malnutrition—Donepezil—Alzheimer's disease	0.00163	0.00206	CcSEcCtD
Nelarabine—Hypotension—Galantamine—Alzheimer's disease	0.00161	0.00202	CcSEcCtD
Nelarabine—Dysgeusia—Donepezil—Alzheimer's disease	0.0016	0.00201	CcSEcCtD
Nelarabine—Eye disorder—Memantine—Alzheimer's disease	0.00159	0.002	CcSEcCtD
Nelarabine—Cardiac disorder—Memantine—Alzheimer's disease	0.00158	0.00199	CcSEcCtD
Nelarabine—Back pain—Donepezil—Alzheimer's disease	0.00158	0.00199	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—PPP3CA—Alzheimer's disease	0.00158	0.0197	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00157	0.00197	CcSEcCtD
Nelarabine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00156	0.00196	CcSEcCtD
Nelarabine—Insomnia—Galantamine—Alzheimer's disease	0.00156	0.00196	CcSEcCtD
Nelarabine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00155	0.00195	CcSEcCtD
Nelarabine—Angiopathy—Memantine—Alzheimer's disease	0.00155	0.00195	CcSEcCtD
Nelarabine—Paraesthesia—Galantamine—Alzheimer's disease	0.00155	0.00194	CcSEcCtD
Nelarabine—Vision blurred—Donepezil—Alzheimer's disease	0.00154	0.00194	CcSEcCtD
Nelarabine—Mediastinal disorder—Memantine—Alzheimer's disease	0.00154	0.00193	CcSEcCtD
Nelarabine—Tremor—Donepezil—Alzheimer's disease	0.00153	0.00193	CcSEcCtD
Nelarabine—Somnolence—Galantamine—Alzheimer's disease	0.00153	0.00192	CcSEcCtD
Nelarabine—Chills—Memantine—Alzheimer's disease	0.00153	0.00192	CcSEcCtD
Nelarabine—DGUOK—Metabolism—DHCR24—Alzheimer's disease	0.00153	0.019	CbGpPWpGaD
Nelarabine—Angiopathy—Rivastigmine—Alzheimer's disease	0.00151	0.0019	CcSEcCtD
Nelarabine—Anaemia—Donepezil—Alzheimer's disease	0.00151	0.0019	CcSEcCtD
Nelarabine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.0015	0.00189	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—BAX—Alzheimer's disease	0.0015	0.0186	CbGpPWpGaD
Nelarabine—Chills—Rivastigmine—Alzheimer's disease	0.0015	0.00188	CcSEcCtD
Nelarabine—Decreased appetite—Galantamine—Alzheimer's disease	0.0015	0.00188	CcSEcCtD
Nelarabine—Mental disorder—Memantine—Alzheimer's disease	0.00149	0.00188	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00149	0.00187	CcSEcCtD
Nelarabine—Malnutrition—Memantine—Alzheimer's disease	0.00148	0.00187	CcSEcCtD
Nelarabine—Fatigue—Galantamine—Alzheimer's disease	0.00148	0.00187	CcSEcCtD
Nelarabine—Constipation—Galantamine—Alzheimer's disease	0.00147	0.00185	CcSEcCtD
Nelarabine—Mental disorder—Rivastigmine—Alzheimer's disease	0.00146	0.00184	CcSEcCtD
Nelarabine—Dysgeusia—Memantine—Alzheimer's disease	0.00145	0.00183	CcSEcCtD
Nelarabine—Malnutrition—Rivastigmine—Alzheimer's disease	0.00145	0.00183	CcSEcCtD
Nelarabine—Loss of consciousness—Donepezil—Alzheimer's disease	0.00144	0.00181	CcSEcCtD
Nelarabine—Back pain—Memantine—Alzheimer's disease	0.00144	0.00181	CcSEcCtD
Nelarabine—Cough—Donepezil—Alzheimer's disease	0.00143	0.00179	CcSEcCtD
Nelarabine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00142	0.00179	CcSEcCtD
Nelarabine—Feeling abnormal—Galantamine—Alzheimer's disease	0.00142	0.00178	CcSEcCtD
Nelarabine—Convulsion—Donepezil—Alzheimer's disease	0.00142	0.00178	CcSEcCtD
Nelarabine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00141	0.00177	CcSEcCtD
Nelarabine—Back pain—Rivastigmine—Alzheimer's disease	0.0014	0.00177	CcSEcCtD
Nelarabine—Vision blurred—Memantine—Alzheimer's disease	0.0014	0.00176	CcSEcCtD
Nelarabine—Myalgia—Donepezil—Alzheimer's disease	0.00139	0.00175	CcSEcCtD
Nelarabine—Chest pain—Donepezil—Alzheimer's disease	0.00139	0.00175	CcSEcCtD
Nelarabine—Arthralgia—Donepezil—Alzheimer's disease	0.00139	0.00175	CcSEcCtD
Nelarabine—Tremor—Memantine—Alzheimer's disease	0.00139	0.00175	CcSEcCtD
Nelarabine—Anaemia—Memantine—Alzheimer's disease	0.00137	0.00173	CcSEcCtD
Nelarabine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00137	0.00172	CcSEcCtD
Nelarabine—Body temperature increased—Galantamine—Alzheimer's disease	0.00136	0.00171	CcSEcCtD
Nelarabine—Abdominal pain—Galantamine—Alzheimer's disease	0.00136	0.00171	CcSEcCtD
Nelarabine—Tremor—Rivastigmine—Alzheimer's disease	0.00136	0.00171	CcSEcCtD
Nelarabine—Confusional state—Donepezil—Alzheimer's disease	0.00135	0.00169	CcSEcCtD
Nelarabine—Anaemia—Rivastigmine—Alzheimer's disease	0.00134	0.00169	CcSEcCtD
Nelarabine—Oedema—Donepezil—Alzheimer's disease	0.00133	0.00168	CcSEcCtD
Nelarabine—Leukopenia—Memantine—Alzheimer's disease	0.00133	0.00167	CcSEcCtD
Nelarabine—Infection—Donepezil—Alzheimer's disease	0.00133	0.00167	CcSEcCtD
Nelarabine—Nervous system disorder—Donepezil—Alzheimer's disease	0.00131	0.00165	CcSEcCtD
Nelarabine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00131	0.00164	CcSEcCtD
Nelarabine—Loss of consciousness—Memantine—Alzheimer's disease	0.0013	0.00164	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—Alzheimer's disease	0.0013	0.0162	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CA4—Alzheimer's disease	0.0013	0.0162	CbGpPWpGaD
Nelarabine—Cough—Memantine—Alzheimer's disease	0.0013	0.00163	CcSEcCtD
Nelarabine—Convulsion—Memantine—Alzheimer's disease	0.00129	0.00162	CcSEcCtD
Nelarabine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00128	0.00161	CcSEcCtD
Nelarabine—Anorexia—Donepezil—Alzheimer's disease	0.00127	0.0016	CcSEcCtD
Nelarabine—Cough—Rivastigmine—Alzheimer's disease	0.00127	0.00159	CcSEcCtD
Nelarabine—Myalgia—Memantine—Alzheimer's disease	0.00126	0.00159	CcSEcCtD
Nelarabine—Chest pain—Memantine—Alzheimer's disease	0.00126	0.00159	CcSEcCtD
Nelarabine—Arthralgia—Memantine—Alzheimer's disease	0.00126	0.00159	CcSEcCtD
Nelarabine—Convulsion—Rivastigmine—Alzheimer's disease	0.00126	0.00158	CcSEcCtD
Nelarabine—Hypotension—Donepezil—Alzheimer's disease	0.00125	0.00157	CcSEcCtD
Nelarabine—Myalgia—Rivastigmine—Alzheimer's disease	0.00124	0.00155	CcSEcCtD
Nelarabine—Chest pain—Rivastigmine—Alzheimer's disease	0.00124	0.00155	CcSEcCtD
Nelarabine—Arthralgia—Rivastigmine—Alzheimer's disease	0.00124	0.00155	CcSEcCtD
Nelarabine—Asthenia—Galantamine—Alzheimer's disease	0.00124	0.00155	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—GSK3B—Alzheimer's disease	0.00122	0.0152	CbGpPWpGaD
Nelarabine—Confusional state—Memantine—Alzheimer's disease	0.00122	0.00154	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GAPDHS—Alzheimer's disease	0.00122	0.0152	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00122	0.00153	CcSEcCtD
Nelarabine—Oedema—Memantine—Alzheimer's disease	0.00121	0.00152	CcSEcCtD
Nelarabine—Insomnia—Donepezil—Alzheimer's disease	0.00121	0.00152	CcSEcCtD
Nelarabine—Infection—Memantine—Alzheimer's disease	0.0012	0.00151	CcSEcCtD
Nelarabine—Paraesthesia—Donepezil—Alzheimer's disease	0.0012	0.00151	CcSEcCtD
Nelarabine—Confusional state—Rivastigmine—Alzheimer's disease	0.00119	0.0015	CcSEcCtD
Nelarabine—Dyspnoea—Donepezil—Alzheimer's disease	0.00119	0.0015	CcSEcCtD
Nelarabine—Nervous system disorder—Memantine—Alzheimer's disease	0.00119	0.00149	CcSEcCtD
Nelarabine—Somnolence—Donepezil—Alzheimer's disease	0.00119	0.00149	CcSEcCtD
Nelarabine—Thrombocytopenia—Memantine—Alzheimer's disease	0.00119	0.00149	CcSEcCtD
Nelarabine—Oedema—Rivastigmine—Alzheimer's disease	0.00118	0.00149	CcSEcCtD
Nelarabine—Diarrhoea—Galantamine—Alzheimer's disease	0.00118	0.00148	CcSEcCtD
Nelarabine—Infection—Rivastigmine—Alzheimer's disease	0.00118	0.00148	CcSEcCtD
Nelarabine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00116	0.00146	CcSEcCtD
Nelarabine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00116	0.00146	CcSEcCtD
Nelarabine—Decreased appetite—Donepezil—Alzheimer's disease	0.00116	0.00146	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ATP5A1—Alzheimer's disease	0.00116	0.0144	CbGpPWpGaD
Nelarabine—Anorexia—Memantine—Alzheimer's disease	0.00115	0.00145	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00115	0.00145	CcSEcCtD
Nelarabine—Fatigue—Donepezil—Alzheimer's disease	0.00115	0.00145	CcSEcCtD
Nelarabine—Pain—Donepezil—Alzheimer's disease	0.00114	0.00143	CcSEcCtD
Nelarabine—Constipation—Donepezil—Alzheimer's disease	0.00114	0.00143	CcSEcCtD
Nelarabine—Dizziness—Galantamine—Alzheimer's disease	0.00114	0.00143	CcSEcCtD
Nelarabine—Hypotension—Memantine—Alzheimer's disease	0.00113	0.00142	CcSEcCtD
Nelarabine—Anorexia—Rivastigmine—Alzheimer's disease	0.00113	0.00142	CcSEcCtD
Nelarabine—Hypotension—Rivastigmine—Alzheimer's disease	0.00111	0.00139	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PLD3—Alzheimer's disease	0.0011	0.0137	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—BAX—Alzheimer's disease	0.0011	0.0137	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.0011	0.00139	CcSEcCtD
Nelarabine—Feeling abnormal—Donepezil—Alzheimer's disease	0.0011	0.00138	CcSEcCtD
Nelarabine—Insomnia—Memantine—Alzheimer's disease	0.0011	0.00138	CcSEcCtD
Nelarabine—Vomiting—Galantamine—Alzheimer's disease	0.00109	0.00138	CcSEcCtD
Nelarabine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00109	0.00137	CcSEcCtD
Nelarabine—Paraesthesia—Memantine—Alzheimer's disease	0.00109	0.00137	CcSEcCtD
Nelarabine—Dyspnoea—Memantine—Alzheimer's disease	0.00108	0.00136	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00108	0.00136	CcSEcCtD
Nelarabine—Headache—Galantamine—Alzheimer's disease	0.00108	0.00136	CcSEcCtD
Nelarabine—Somnolence—Memantine—Alzheimer's disease	0.00108	0.00135	CcSEcCtD
Nelarabine—Insomnia—Rivastigmine—Alzheimer's disease	0.00107	0.00135	CcSEcCtD
Nelarabine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00106	0.00134	CcSEcCtD
Nelarabine—DGUOK—Metabolism—HSD17B10—Alzheimer's disease	0.00106	0.0132	CbGpPWpGaD
Nelarabine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00106	0.00133	CcSEcCtD
Nelarabine—Body temperature increased—Donepezil—Alzheimer's disease	0.00105	0.00133	CcSEcCtD
Nelarabine—Abdominal pain—Donepezil—Alzheimer's disease	0.00105	0.00133	CcSEcCtD
Nelarabine—Somnolence—Rivastigmine—Alzheimer's disease	0.00105	0.00132	CcSEcCtD
Nelarabine—Decreased appetite—Memantine—Alzheimer's disease	0.00105	0.00132	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00105	0.00132	CcSEcCtD
Nelarabine—Fatigue—Memantine—Alzheimer's disease	0.00104	0.00131	CcSEcCtD
Nelarabine—Constipation—Memantine—Alzheimer's disease	0.00104	0.0013	CcSEcCtD
Nelarabine—Pain—Memantine—Alzheimer's disease	0.00104	0.0013	CcSEcCtD
Nelarabine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00103	0.0013	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00102	0.00129	CcSEcCtD
Nelarabine—Nausea—Galantamine—Alzheimer's disease	0.00102	0.00129	CcSEcCtD
Nelarabine—Fatigue—Rivastigmine—Alzheimer's disease	0.00102	0.00128	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CYP46A1—Alzheimer's disease	0.00102	0.0127	CbGpPWpGaD
Nelarabine—Constipation—Rivastigmine—Alzheimer's disease	0.00101	0.00127	CcSEcCtD
Nelarabine—Pain—Rivastigmine—Alzheimer's disease	0.00101	0.00127	CcSEcCtD
Nelarabine—Feeling abnormal—Memantine—Alzheimer's disease	0.000998	0.00126	CcSEcCtD
Nelarabine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00099	0.00125	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ND1—Alzheimer's disease	0.000984	0.0122	CbGpPWpGaD
Nelarabine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000976	0.00123	CcSEcCtD
Nelarabine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000969	0.00122	CcSEcCtD
Nelarabine—Abdominal pain—Memantine—Alzheimer's disease	0.000958	0.0012	CcSEcCtD
Nelarabine—Body temperature increased—Memantine—Alzheimer's disease	0.000958	0.0012	CcSEcCtD
Nelarabine—Asthenia—Donepezil—Alzheimer's disease	0.000957	0.0012	CcSEcCtD
Nelarabine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000937	0.00118	CcSEcCtD
Nelarabine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000937	0.00118	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—CHRNB2—Alzheimer's disease	0.000917	0.0114	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—CST3—Alzheimer's disease	0.000917	0.0114	CbGpPWpGaD
Nelarabine—Diarrhoea—Donepezil—Alzheimer's disease	0.000913	0.00115	CcSEcCtD
Nelarabine—Dizziness—Donepezil—Alzheimer's disease	0.000882	0.00111	CcSEcCtD
Nelarabine—Asthenia—Memantine—Alzheimer's disease	0.000869	0.00109	CcSEcCtD
Nelarabine—Asthenia—Rivastigmine—Alzheimer's disease	0.00085	0.00107	CcSEcCtD
Nelarabine—Vomiting—Donepezil—Alzheimer's disease	0.000848	0.00107	CcSEcCtD
Nelarabine—Headache—Donepezil—Alzheimer's disease	0.000836	0.00105	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—CRH—Alzheimer's disease	0.000833	0.0104	CbGpPWpGaD
Nelarabine—Diarrhoea—Memantine—Alzheimer's disease	0.000829	0.00104	CcSEcCtD
Nelarabine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000811	0.00102	CcSEcCtD
Nelarabine—Dizziness—Memantine—Alzheimer's disease	0.000801	0.00101	CcSEcCtD
Nelarabine—Nausea—Donepezil—Alzheimer's disease	0.000792	0.000997	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—NPS—Alzheimer's disease	0.000789	0.00983	CbGpPWpGaD
Nelarabine—Dizziness—Rivastigmine—Alzheimer's disease	0.000784	0.000986	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—SLC6A4—Alzheimer's disease	0.000774	0.00964	CbGpPWpGaD
Nelarabine—Vomiting—Memantine—Alzheimer's disease	0.00077	0.000969	CcSEcCtD
Nelarabine—Headache—Memantine—Alzheimer's disease	0.000759	0.000954	CcSEcCtD
Nelarabine—Vomiting—Rivastigmine—Alzheimer's disease	0.000753	0.000948	CcSEcCtD
Nelarabine—Headache—Rivastigmine—Alzheimer's disease	0.000742	0.000934	CcSEcCtD
Nelarabine—Nausea—Memantine—Alzheimer's disease	0.000719	0.000905	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000719	0.00895	CbGpPWpGaD
Nelarabine—Nausea—Rivastigmine—Alzheimer's disease	0.000704	0.000885	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—PLAU—Alzheimer's disease	0.00068	0.00847	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000665	0.00828	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NGFR—Alzheimer's disease	0.000646	0.00804	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000645	0.00803	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—BCL2—Alzheimer's disease	0.00064	0.00797	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—TPI1—Alzheimer's disease	0.000634	0.00789	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CHAT—Alzheimer's disease	0.000634	0.00789	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—PTGS2—Alzheimer's disease	0.000608	0.00757	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—MAOB—Alzheimer's disease	0.000608	0.00757	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000604	0.00751	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000593	0.00738	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GAPDH—Alzheimer's disease	0.000585	0.00728	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	0.000579	0.0072	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—A2M—Alzheimer's disease	0.000565	0.00703	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000525	0.00654	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000516	0.00643	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PRKCG—Alzheimer's disease	0.000512	0.00637	CbGpPWpGaD
Nelarabine—ADA—Metabolism—DHCR24—Alzheimer's disease	0.000507	0.00631	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ACHE—Alzheimer's disease	0.000492	0.00612	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—INPP5D—Alzheimer's disease	0.000486	0.00605	CbGpPWpGaD
Nelarabine—DCK—Metabolism—DHCR24—Alzheimer's disease	0.000468	0.00582	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTGS1—Alzheimer's disease	0.000461	0.00573	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ENO1—Alzheimer's disease	0.000461	0.00573	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP2D6—Alzheimer's disease	0.000452	0.00562	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—LEP—Alzheimer's disease	0.000442	0.0055	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CA4—Alzheimer's disease	0.000431	0.00536	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—BCHE—Alzheimer's disease	0.000428	0.00533	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NOS2—Alzheimer's disease	0.000411	0.00512	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GAPDHS—Alzheimer's disease	0.000405	0.00504	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PLCB1—Alzheimer's disease	0.000404	0.00503	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CA4—Alzheimer's disease	0.000398	0.00495	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000396	0.00492	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCA1—Alzheimer's disease	0.000392	0.00488	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PPARG—Alzheimer's disease	0.000385	0.00479	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ATP5A1—Alzheimer's disease	0.000384	0.00478	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—GSK3B—Alzheimer's disease	0.000382	0.00476	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—CREB1—Alzheimer's disease	0.000379	0.00472	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GAPDHS—Alzheimer's disease	0.000374	0.00465	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000368	0.00458	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLD3—Alzheimer's disease	0.000366	0.00456	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ATP5A1—Alzheimer's disease	0.000355	0.00441	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HSD17B10—Alzheimer's disease	0.000351	0.00437	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLD3—Alzheimer's disease	0.000338	0.00421	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP46A1—Alzheimer's disease	0.000338	0.00421	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARGC1A—Alzheimer's disease	0.000338	0.0042	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HMOX1—Alzheimer's disease	0.000336	0.00418	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ND1—Alzheimer's disease	0.000327	0.00407	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—Alzheimer's disease	0.000325	0.00404	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HSD17B10—Alzheimer's disease	0.000324	0.00404	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP46A1—Alzheimer's disease	0.000312	0.00389	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LPL—Alzheimer's disease	0.000307	0.00383	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ND1—Alzheimer's disease	0.000301	0.00375	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000297	0.00369	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—MTHFR—Alzheimer's disease	0.000277	0.00344	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000267	0.00332	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CALM1—Alzheimer's disease	0.000259	0.00322	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—MAPK8—Alzheimer's disease	0.000258	0.00321	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOE—Alzheimer's disease	0.000258	0.00321	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.000257	0.0032	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CAV1—Alzheimer's disease	0.000255	0.00318	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—Alzheimer's disease	0.000238	0.00296	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARG—Alzheimer's disease	0.000224	0.00279	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.000224	0.00279	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—INS—Alzheimer's disease	0.00022	0.00274	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.000213	0.00265	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CHAT—Alzheimer's disease	0.00021	0.00262	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TPI1—Alzheimer's disease	0.00021	0.00262	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MAOB—Alzheimer's disease	0.000202	0.00251	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.000198	0.00246	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TPI1—Alzheimer's disease	0.000194	0.00242	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CHAT—Alzheimer's disease	0.000194	0.00242	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GAPDH—Alzheimer's disease	0.000194	0.00242	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NOS3—Alzheimer's disease	0.000193	0.0024	CbGpPWpGaD
Nelarabine—ADA—Metabolism—A2M—Alzheimer's disease	0.000188	0.00234	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MAOB—Alzheimer's disease	0.000186	0.00232	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.000182	0.00226	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TP53—Alzheimer's disease	0.00018	0.00224	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GAPDH—Alzheimer's disease	0.000179	0.00223	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTGS2—Alzheimer's disease	0.000177	0.0022	CbGpPWpGaD
Nelarabine—DCK—Metabolism—A2M—Alzheimer's disease	0.000173	0.00216	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.000168	0.00209	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—IL6—Alzheimer's disease	0.000165	0.00205	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ACHE—Alzheimer's disease	0.000163	0.00203	CbGpPWpGaD
Nelarabine—ADA—Metabolism—INPP5D—Alzheimer's disease	0.000161	0.00201	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.000154	0.00192	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS1—Alzheimer's disease	0.000153	0.0019	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ENO1—Alzheimer's disease	0.000153	0.0019	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ACHE—Alzheimer's disease	0.000151	0.00187	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP2D6—Alzheimer's disease	0.00015	0.00187	CbGpPWpGaD
Nelarabine—DCK—Metabolism—INPP5D—Alzheimer's disease	0.000149	0.00185	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.000144	0.00179	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BCHE—Alzheimer's disease	0.000142	0.00177	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ENO1—Alzheimer's disease	0.000141	0.00176	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS1—Alzheimer's disease	0.000141	0.00176	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2D6—Alzheimer's disease	0.000138	0.00172	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLCB1—Alzheimer's disease	0.000134	0.00167	CbGpPWpGaD
Nelarabine—DCK—Metabolism—BCHE—Alzheimer's disease	0.000131	0.00163	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCA1—Alzheimer's disease	0.00013	0.00162	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.000127	0.00158	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLCB1—Alzheimer's disease	0.000124	0.00154	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCA1—Alzheimer's disease	0.00012	0.00149	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARGC1A—Alzheimer's disease	0.000112	0.0014	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMOX1—Alzheimer's disease	0.000112	0.00139	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.000107	0.00133	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARGC1A—Alzheimer's disease	0.000103	0.00129	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HMOX1—Alzheimer's disease	0.000103	0.00128	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LPL—Alzheimer's disease	0.000102	0.00127	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LPL—Alzheimer's disease	9.42e-05	0.00117	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTHFR—Alzheimer's disease	9.19e-05	0.00114	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—Alzheimer's disease	8.87e-05	0.0011	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CALM1—Alzheimer's disease	8.58e-05	0.00107	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOE—Alzheimer's disease	8.55e-05	0.00106	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTHFR—Alzheimer's disease	8.48e-05	0.00106	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAV1—Alzheimer's disease	8.47e-05	0.00105	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CALM1—Alzheimer's disease	7.92e-05	0.000986	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOE—Alzheimer's disease	7.89e-05	0.000983	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAV1—Alzheimer's disease	7.82e-05	0.000973	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARG—Alzheimer's disease	7.45e-05	0.000927	CbGpPWpGaD
Nelarabine—ADA—Metabolism—INS—Alzheimer's disease	7.31e-05	0.00091	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARG—Alzheimer's disease	6.88e-05	0.000856	CbGpPWpGaD
Nelarabine—DCK—Metabolism—INS—Alzheimer's disease	6.74e-05	0.000839	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NOS3—Alzheimer's disease	6.41e-05	0.000798	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NOS3—Alzheimer's disease	5.91e-05	0.000736	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—Alzheimer's disease	5.86e-05	0.000729	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—Alzheimer's disease	5.48e-05	0.000683	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—Alzheimer's disease	5.41e-05	0.000673	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—Alzheimer's disease	2.95e-05	0.000367	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—Alzheimer's disease	2.72e-05	0.000338	CbGpPWpGaD
